{"id":186021,"date":"2025-09-05T00:00:00","date_gmt":"2025-09-05T00:00:00","guid":{"rendered":"https:\/\/medgoo.com\/index.php\/2025\/09\/05\/moderate-to-severe-tbi-linked-to-malignant-brain-tumor-risk\/"},"modified":"2025-09-08T17:10:36","modified_gmt":"2025-09-08T17:10:36","slug":"moderate-to-severe-tbi-linked-to-malignant-brain-tumor-risk","status":"publish","type":"post","link":"https:\/\/medgoo.com\/index.php\/2025\/09\/05\/moderate-to-severe-tbi-linked-to-malignant-brain-tumor-risk\/","title":{"rendered":"Moderate-to-Severe TBI Linked to Malignant Brain Tumor Risk"},"content":{"rendered":"<h3>\n<p>Moderate-to-severe traumatic brain injury group had significantly higher risk for developing malignant brain tumors versus mild TBI group<\/p>\n<\/h3>\n<p><b>By Elana Gotkine HealthDay Reporter<\/b><br \/>\n<b><\/b><\/p>\n<p>FRIDAY, Sept. 5, 2025 (HealthDay News) &#8212; A history of moderate-to-severe traumatic brain injury (TBI) is associated with an increased risk for developing malignant brain tumors, according to a study published online Aug. 25 in<em> JAMA Network Open<\/em>.<\/p>\n<p>Sandro Marini, M.D., from Brigham and Women&#8217;s Hospital in Boston, and colleagues conducted a retrospective cohort study using data from a tertiary academic medical center (Mass General Brigham) to examine whether the history of TBI in U.S. adult civilians is associated with a risk for subsequent development of malignant brain tumors. Adults with mild TBI or moderate-to-severe TBI (exposure group; 75,679 participants) were compared to an age- and sex-matched group without TBI history (control group; 75,679 participants).<\/p>\n<p>Of the civilians with TBI, 60,735 and 14,944 had mild TBI and moderate-to-severe TBI, respectively. The median duration of follow-up was 7.2 years. The researchers found that the prevalence of malignant brain tumors was 0.6 and 0.4 percent in the moderate-to-severe TBI group and the control and mild TBI groups, respectively. The risk for developing malignant brain tumors was significantly higher for the moderate-to-severe TBI group (hazard ratio, 1.67) versus the mild TBI group. When these data were meta-analyzed with data from two other centers (University of California Health and Northwestern Medicine), the risk persisted (hazard ratio, 1.57).<\/p>\n<p>&#8220;While there is an increased risk of tumor from TBI, the overall risk remains low. Still, brain tumor is a devastating disease and often gets detected in later stages,&#8221; Marini said in a statement. &#8220;Now, we&#8217;ve opened the door to monitor TBI patients more closely.&#8221;<\/p>\n<p>Several authors disclosed ties to the biopharmaceutical and medical device industries; one author was a named inventor on patents.<\/p>\n<p><a href=\"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2837955\">Abstract\/Full Text<\/a><\/p>\n<p><i><\/i><br \/>\n<i>Copyright &#169; 2025 <a href=\"https:\/\/consumer.healthday.com\/\" target=\"_new\">HealthDay<\/a>. All rights reserved.<\/i><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Moderate-to-severe traumatic brain injury group had significantly higher risk for developing malignant brain tumors versus mild TBI group<\/p>\n","protected":false},"author":6,"featured_media":186517,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[6],"tags":[11],"class_list":["post-186021","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","tag-news"],"_links":{"self":[{"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/posts\/186021","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/comments?post=186021"}],"version-history":[{"count":1,"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/posts\/186021\/revisions"}],"predecessor-version":[{"id":186275,"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/posts\/186021\/revisions\/186275"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/media\/186517"}],"wp:attachment":[{"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/media?parent=186021"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/categories?post=186021"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/tags?post=186021"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}